Correlation Between VIRI Old and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both VIRI Old and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRI Old and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIRI Old and Regen BioPharma, you can compare the effects of market volatilities on VIRI Old and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRI Old with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRI Old and Regen BioPharma.
Diversification Opportunities for VIRI Old and Regen BioPharma
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between VIRI and Regen is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding VIRI Old and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and VIRI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRI Old are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of VIRI Old i.e., VIRI Old and Regen BioPharma go up and down completely randomly.
Pair Corralation between VIRI Old and Regen BioPharma
Given the investment horizon of 90 days VIRI Old is expected to under-perform the Regen BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, VIRI Old is 1.84 times less risky than Regen BioPharma. The stock trades about -0.07 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Regen BioPharma on November 2, 2024 and sell it today you would lose (8.79) from holding Regen BioPharma or give up 58.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 42.86% |
| Values | Daily Returns |
VIRI Old vs. Regen BioPharma
Performance |
| Timeline |
| VIRI Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Regen BioPharma |
VIRI Old and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VIRI Old and Regen BioPharma
The main advantage of trading using opposite VIRI Old and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRI Old position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| VIRI Old vs. LMF Acquisition Opportunities | VIRI Old vs. ZyVersa Therapeutics | VIRI Old vs. Sonnet Biotherapeutics Holdings | VIRI Old vs. Revelation Biosciences |
| Regen BioPharma vs. Creative Medical Technology | Regen BioPharma vs. Therasense | Regen BioPharma vs. Enzolytics | Regen BioPharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |